Suma Genomics offers prenatal diagnosis on request by the doctors and centers that are registered under the Preconception and Prenatal Diagnostic Techniques (PC-PNDT) Act, 1994.
Tests offered
• Rapid aneuploidy testing for chromosomes 13, 18, 21, X and Y by QF-PCR
• Prenatal diagnosis of any monogenic disease, detection of common aneuploidies and maternal cell contamination (if a diagnosis is established in the proband or if the parents are confirmed carriers)
Sample requirement
We accept amniotic fluid (10 ml), chorionic villi (10-20 mg or 10-12 clean villi), fetal blood (1-2 ml in EDTA vacutainers) or fetal DNA. Kindly provide sufficient samples for the test and transport in leak proof containers with due precautions for transport of biological samples.
Always provide 2 ml EDTA blood samples of parents along with fetal sample for testing maternal cell contamination and if necessary, to confirm the variant/s.
Pretest and post-test counseling
We assume the referring physician has conducted/arranged/assumes full responsibility of pretest and post-test genetic counseling. We will send the reports only to the referring doctor via secure emails. We do not send the reports to the patients.
Clinical information
We urge the doctors to provide – detailed clinical information – and genetic test reports of previous child or parents.
Consents and test request forms
The referring physician should provide us the written consent of the patient in the suggested format along with the test request form, duly signed.
Requirements as per PC-PNDT act
Suma Genomics Private Limited, Manipal is registered under this act. We do not reveal the sex of the baby in any manner. The referring doctor takes the responsibility of obtaining fetal samples and maintaining appropriate records. Kindly provide pre-filled form E (provided by us) to Suma Genomics along with the samples.
For more information, please contact us at office@sumagenomics.in. We also request you to intimate us of the test request in advance.
Podcasting operational change management inside of workflows to establish a framework. Taking seamless key performance indicators offline to maximise the long tail.
Collaboratively administrate empowered markets via plug-and-play networks. Dynamically procrastinate B2C users after installed base benefits.
Dramatically visualize customer directed convergence without revolutionary ROI.
Keeping your eye on the ball while performing a deep dive on the start-up mentality to derive convergence on cross-platform integration.